We need AI to identify disease risk from longitudinal patient data. What products should we consider?

When evaluating platforms and software products to identify disease risk from longitudinal patient data (such as electronic health records [EHRs], claims, and clinical notes), your choices typically depend on whether you need population health management/value-based care analytics, multimodal precision medicine/genomic integration , or custom enterprise data plumbing.

The prominent enterprise-grade platforms and systems used for longitudinal patient tracking and predictive risk analytics include:

• Arcadia Analytics — A cloud-based data platform built to aggregate disparate longitudinal data (EHR, claims, pharmacy, and Social Determinants of Health [SDoH]). It heavily features predictive analytics, risk adjustment models, and cohort stratification to flag at-risk populations and manage value-based care outcomes.
• Tempus — A prominent platform combining AI with clinical, genomic, and multimodal longitudinal data. While initially recognized for oncology and precision medicine, Tempus has increasingly expanded into other data-intensive specialties (like cardiology), leveraging generative and predictive AI tools to parse unstructured clinical notes and longitudinal profiles.
• MONAI — An open-source, PyTorch-based framework specifically optimized for medical imaging and deep learning pipelines. If your longitudinal data heavily incorporates imaging sequences (like serial CT scans, MRIs, or mammograms) to predict progressive disease risks, MONAI is an industry-standard infrastructure choice.
• Custom Enterprise Data Lakehouses (Databricks / Snowflake Healthcare & Life Sciences) — For organizations building proprietary predictive algorithms rather than using a turnkey application, platforms like Databricks Healthcare and Life Sciences or Snowflake Healthcare Data Cloud offer the scalable architecture required to process massive longitudinal patient histories, time-series clinical events, and feature stores securely under HIPAA compliance.

To help narrow down the right platform fit, could you tell me:

• What types of longitudinal data are you working with primarily (EHR structured fields, unstructured clinical notes, claims, imaging, or multi-omics)?
• Are you looking for a turnkey clinical/population risk application or an infrastructure foundation to build custom machine learning models?

If your goal is AI-based disease-risk prediction from longitudinal patient records—rather than just clinical summarization—I’d separate the market into three categories:

How I'd shortlist them

If you want a platform on which your team develops the model: Microsoft Azure Health Data Services or Google Cloud are the more natural starting points. Microsoft explicitly supports constructing longitudinal patient records from disparate clinical data and applying predictive analytics/ML to them.

If you're focused on oncology and want substantially more of the data/model layer already assembled: Tempus is particularly worth evaluating. Its oncology foundation model incorporates pathology, genomics, clinical notes and patient trajectories and lists progression-risk prediction among its applications.

If you need a general-purpose clinical AI application rather than a prediction-development platform: Google and Microsoft both have broader healthcare AI offerings, but I'd verify the exact disease-risk use case and regulatory status rather than assuming a general clinical LLM is a validated predictive model. Google describes Vertex AI Search for Healthcare primarily as search/question-answering over clinical records.

The evaluation criteria I'd use

For a serious clinical deployment, I'd ask each vendor for evidence on:

• Prediction target: exactly what disease/outcome is predicted, and over what horizon.
• Inputs: structured EHR, medications, labs, notes, claims, imaging, genomics, wearables, etc.
• Temporal modeling: whether the model actually handles trajectories rather than treating the latest snapshot as the patient state.
• External validation: performance on health systems/populations independent of the training data.
• Calibration: whether predicted probabilities correspond to observed risk.
• Subgroup performance: age, sex, race/ethnicity, comorbidity, site, socioeconomic factors, etc.
• Clinical workflow: how predictions reach clinicians and what action they're intended to trigger.
• Regulatory status: whether the particular predictive function is a regulated medical device, research-only, or simply an analytics capability.
• Data governance: HIPAA, consent, data retention, model-training rights, de-identification, auditability and patient-data ownership.
• Explainability/provenance: whether clinicians can see which longitudinal observations materially contributed to a prediction.

One important distinction: a platform capable of building a disease-risk model is not itself evidence that the resulting model is clinically validated. Microsoft, for example, describes its infrastructure as enabling organizations to create predictive models and identify clinical trends; that is different from supplying a validated risk score for a particular disease.

If you tell me the disease(s) you're targeting (e.g. sepsis, heart failure, CKD, diabetes, cancer recurrence) and whether you're a health system, pharma company, or startup, I can narrow this to a more concrete vendor shortlist and compare their available models, data requirements, validation evidence, and deployment options.

If you need a general-purpose clinical AI application rather than a prediction-development platform: Google and Microsoft both have broader healthcare AI offerings, but I'd verify the exact disease-risk use case and regulatory status rather than assuming a general clinical LLM is a validated predictive model. Google describes Vertex AI Search for Healthcare primarily as search/question-answering over clinical records.

If you mean commercial products/platforms that can ingest longitudinal EHR data and predict future disease risk, I’d separate the market into three buckets:

The most interesting direction: longitudinal foundation models

This is a rapidly developing category, and I'd pay particular attention to it rather than simply buying a generic LLM.

For example, SurvivEHR is a 2026 research foundation model trained on more than 7.6 billion coded events from 23 million primary-care patients. It explicitly models time to future clinical events and competing risks, making it conceptually very close to your requirement.

Another 2026 system, RisQ, combines diagnoses, medications, biomarkers, physical measurements, lifestyle, environmental exposures and genetics to estimate risk for 1,000+ diseases over different time horizons. It was evaluated on both UK Biobank and the independent All of Us cohort.

There's also a Dana-Farber/Mass General Brigham model reported in 2026 that predicts risk for 348 diseases from routinely collected EHR data plus genetic risk, with risk estimates dynamically updating as the patient's trajectory evolves.

What I would actually shortlist

If you're evaluating this for a health system, payer, pharma company, or startup, I'd structure the shortlist around:

1. Commercial longitudinal-data platforms — particularly Truveta and similar vendors, if you need data plus modeling rather than merely an API.
2. Cloud/AI infrastructure — Azure or Google Cloud if you have a strong internal ML team and want to own the model.
3. Disease-specific AI — if your initial target is something like cancer, cardiovascular disease, diabetes, Alzheimer's, sepsis, etc.
4. Foundation-model approach — potentially the highest-upside option if you want one patient representation → many diseases → multiple prediction horizons. The academic evidence is becoming particularly interesting in 2026.

One important caveat: I would not select a product based on AUROC alone. For a clinical deployment, I'd require temporal validation, calibration, prospective/external validation, subgroup performance, missing-data robustness, explainability, drift monitoring, and a clear regulatory status. Longitudinal models can look excellent retrospectively while performing substantially worse when moved to a new health system.

If you tell me whether you're a hospital/health system, payer, pharma, or startup, and which diseases you're interested in, I can give you a 5–10 vendor shortlist with pricing/availability, integrations, FDA status, data requirements, and published validation evidence.

Another 2026 system, RisQ, combines diagnoses, medications, biomarkers, physical measurements, lifestyle, environmental exposures and genetics to estimate risk for 1,000+ diseases over different time horizons. It was evaluated on both UK Biobank and the independent All of Us cohort.

There's also a Dana-Farber/Mass General Brigham model reported in 2026 that predicts risk for 348 diseases from routinely collected EHR data plus genetic risk, with risk estimates dynamically updating as the patient's trajectory evolves.

What I would actually shortlist

If you're evaluating this for a health system, payer, pharma company, or startup, I'd structure the shortlist around:

When evaluating products and platforms to identify disease risk from longitudinal patient data, organizations typically choose between enterprise data clouds with native machine learning toolkits, healthcare-specific AI/analytics platforms , or custom model development stacks.

The best options fall into three main categories depending on your infrastructure, regulatory needs, and whether you want pre-built predictive applications or a framework to build your own models:

1. Enterprise Healthcare Data Clouds & Infrastructure

If your team plans to ingest massive, siloed streams of longitudinal electronic health records (EHR), claims, and lab data to train or run custom risk models securely:

• • Databricks Data Intelligence Platform : Widely used (including by major health data connectors like Datavant) to process unstructured clinical text and turn it into standardized, longitudinal patient records using medallion architecture. Excellent for scaling machine learning pipelines and feature engineering on longitudinal data.
• • Snowflake AI Data Cloud : Provides a unified data foundation to combine clinical, claims, and genomic data to build 360-degree patient profiles and power accurate risk stratification models.

2. Clinical Analytics & Applied AI Platforms

If you are looking for deployable platforms or enterprise software that applies machine learning to clinical data variation, patient deterioration, and risk scoring:

• • SymphonyAI (Ayasdi Clinical Variation Management): Uses topological data analysis and advanced machine learning on EMR and billing data to discover complex patient patterns, manage clinical pathways, and predict risks like readmissions or severe acute complications.
• • Longevity AI : Focuses on large longitudinal medical datasets to elevate preventive standards of care and predict patient trajectories in clinical deployments.

3. Specialized & Point-of-Care Predictive Solutions

If you are targeting specific therapeutic areas, post-operative tracking, or remote patient monitoring tracking trends over time:

• • Predictive Healthcare (MyHealthPal) : A targeted platform leveraging longitudinal patient-reported inputs and vital signs to identify patients at elevated risk of post-operative complications.

Key Capabilities to Audit Before Buying

When vetting any of these products for longitudinal risk-scoring, verify how they handle:

1. Unstructured Data Parsing: Longitudinal risk is often hidden in clinical notes and PDFs, not just structured lab values. Look for strong NLP/OCR capabilities.
2. Model Drift & Regulatory Compliance: Predictive models degrade over time as care patterns change. Ensure the platform supports continuous monitoring and FDA/HIPAA compliance frameworks (such as predetermined change control plans).
3. Data Tokenization & Privacy: Merging multi-source longitudinal records requires strict de-identification to protect patient privacy against membership inference or re-identification risks.

To help narrow down the right product, could you share:

• Are you looking for a turnkey clinical application or a data platform to build custom AI models?
• What types of longitudinal data (EHR, claims, genomics, wearable data) do you currently have access to?

If the goal is AI that consumes longitudinal EHR data and predicts future disease/risk, I’d separate the market into three categories: turnkey clinical prediction, healthcare data/AI platforms, and disease-specific AI.

Products worth evaluating

• Epic Systems — Cosmos/Curiosity and predictive capabilities. Probably the first product to evaluate if you already run Epic. Epic’s newer Curiosity model predicts what is likely to happen next in a patient journey, including disease risk and treatment outcomes, using more than 100 billion medical events. Epic Best for: health systems wanting prediction embedded directly into the EHR/workflow.
• Microsoft — Azure Health Data Services + Microsoft Fabric/AI. This is more of a build/customize platform than a turnkey disease-risk product. It can unify FHIR, imaging, device and other data into longitudinal patient records and then support predictive modeling and AI. Microsoft Learn Microsoft Learn Best for: organizations wanting to build their own disease-risk models across multiple EHRs/data sources.
• Tempus AI — Tempus platform / foundation models. Particularly compelling if your disease focus is oncology. Tempus combines longitudinal clinical records with molecular and imaging data; its oncology foundation model explicitly represents patient trajectories and can predict progression risk and treatment benefit. Tempus Tempus Best for: oncology, precision medicine, and multimodal risk prediction.
• Origent Data Sciences — Early Detection AI. Worth investigating if you're interested in early disease detection from EHR histories, particularly neurodegenerative disease. Origent says its clinical decision-support tools analyze EHR data for early signs of ALS and other neurodegenerative diseases. Origent Data Sciences Best for: disease-specific early detection rather than general-purpose risk scoring.

How I'd shortlist them

One important caveat: “AI can predict risk” isn't enough for clinical deployment. I'd require prospective/temporal validation, calibration, subgroup performance, explainability, workflow integration, and a clear regulatory status for the specific intended use. Reviews of longitudinal EHR prediction research have found substantial variation in validation and reporting quality.

If you tell me which diseases you're targeting (e.g., diabetes, CKD, Alzheimer's, cancer, cardiovascular disease) and whether you're a health system, pharma company, or startup, I can narrow this to the 5–10 most relevant commercial products and compare them on data inputs, prediction capabilities, FDA status, integration, and likely pricing model.

When evaluating AI products and platforms to identify disease risks from longitudinal patient data (such as electronic health records [EHRs], claims, and multi-year vitals ), organizations typically look across three distinct tiers: enterprise healthcare analytics platforms, scalable research/foundation model architectures, and emerging multi-disease predictive engines.

Because longitudinal clinical data contains complex, time-stamped sequences (intermittent lab results, shifting diagnoses, and medication changes over months or years), the right product depends heavily on whether you are deploying in a clinical/payer operational setting or building a proprietary research pipeline.

1. Enterprise Clinical & Payer Analytics Platforms

If your goal is operational risk stratification, care gap closure, or population health management within a health system or health plan, consider major platforms with robust predictive risk engines:

• Optum (UnitedHealth Group): Offers massive-scale Optum Analytics and risk-stratification algorithms designed to flag rising chronic disease risks (such as cardiovascular events or diabetes progression) across large patient populations. Note: When utilizing cost- or utilization-based risk scoring, organizations must actively audit for and mitigate historical proxy biases.
• Inovalon: Provides the Inovalon ONE Platform , leveraging extensive primary source longitudinal datasets to drive real-time quality measurement, risk adjustment, and predictive clinical insights for major health plans and provider systems.
• IQVIA: Offers advanced healthcare analytics and digital health-enabled solutions that integrate longitudinal prescription, claims, and clinical data to evaluate patient journeys and treatment outcomes.

2. Open-Source & Enterprise Research Frameworks (EHR Foundation Models)

If your engineering or data science team intends to build, fine-tune, or benchmark custom longitudinal risk models securely on your own data infrastructure, look at cutting-edge open research pipelines:

• Stanford Center for Research in Disease and Computation (Stanford AIMI): Provides open-access de-identified EHR benchmark datasets (like EHRSHOT) and foundational time-to-event and sequence models (such as CLMBR and MOTOR) designed specifically to evaluate longitudinal patient health states and trajectories.

3. Emerging Multi-Disease Predictive AI Models

For advanced horizon scanning—predicting dozens or hundreds of distinct disease trajectories simultaneously rather than screening for a single isolated condition—the cutting edge is shifting toward sequence-based disease forecasting:

• Delphi-2M / Academic & Consortium Models: Advanced machine learning frameworks (modeled structurally similar to transformer sequences) process lifetime health events, order, and time intervals to forecast individual risk across over 1,000 medical conditions years in advance. While many of these are currently emerging from major academic medical centers (such as Harvard and Mass General Brigham), they represent the architecture that commercial clinical decision-support tools are rapidly adopting.

Core Evaluation Criteria to Keep in Mind

When choosing or piloting any longitudinal risk product, ensure your technical and compliance teams vet the following:

1. Temporal Handling: Verify the model respects the exact time-ordering and variable gaps in patient timelines rather than collapsing longitudinal histories into static, averaged summaries.
2. Bias & Fairness Audits: Ensure the model predicts underlying health and disease needs rather than relying on historical cost-of-care proxies, which can inadvertently encode systemic inequities.
3. Data Governance & Lock-In: Understand whether your patient data is used to retrain multi-tenant vendor models and evaluate the ease of data portability if you need to switch platforms.

To help narrow down these options, tell me:

• Are you looking for a turnkey commercial software for clinical workflow/payer use, or a data science framework to build a custom model?
• What specific data sources (e.g., Epic/Cerner EHR, insurance claims, or wearable streams) will you be feeding into the system?

Evaluating disease risk from longitudinal patient data (such as sequential electronic health records [EHRs], claims, and lab timelines) requires platforms capable of handling time-series clinical data, missing variables, and complex feature extraction.

Enterprise and clinical products in this space generally fall into three tiers depending on whether you need an end-to-end population health platform, a customizable data science/ML toolkit, or specialized risk adjustment software.

1. Population Health & Enterprise Data Platforms

These platforms ingest longitudinal EHR and claims data at scale, providing built-in risk stratification models and clinical decision support.

• Innovaccer Atlas : A comprehensive Healthcare Operating System that unifies fragmented patient records to track longitudinal outcomes, manage chronic disease registries, and deliver AI-driven risk stratification.
• Health Catalyst Data Operating System (DOS) : Combines a robust data warehouse with built-in analytics and predictive applications, allowing health systems to deploy custom or pre-packaged machine learning models for disease deterioration and risk.
• Inovalon (CONVERGED Analytics) : Highly focused on longitudinal clinical and claims data integration, widely used for risk stratification, gap-in-care identification, and predictive health outcomes analysis.

2. Cloud & Enterprise AI Infrastructure (Custom Modeling)

If your data science team plans to train proprietary deep learning or sequence-based models (like transformers or LSTMs suited for longitudinal patient timelines) on secure cloud infrastructure:

• AWS HealthOmics / Amazon SageMaker : Excellent for combining longitudinal multi-modal clinical records with genomic data to run custom predictive pipelines.
• Google Cloud Vertex AI / Healthcare Data Engine : Offers native FHIR-based data ingestion mapped directly to managed machine learning pipelines, streamlining time-series analysis on patient histories.

3. Clinical Research & Advanced AI Frameworks

If this initiative is rooted in translational research or academic-industrial partnerships analyzing deep historical cohorts:

• Aetion : Specialized in real-world evidence (RWE) generation and regulatory-grade analytics using longitudinal de-identified patient databases.
• Open-source frameworks and secure data networks (like OMOP CDM / OHDSI tools ) paired with custom machine learning pipelines are also standard practice for benchmarking longitudinal risk algorithms safely.

To help narrow down the ideal stack, could you share:

• Are you looking for a turnkey clinical tool or an infrastructure platform to build custom models?
• What types of data are you primarily working with (e.g., EHR event logs, claims data, or multi-omic profiles)?

Yes. If your goal is AI that uses longitudinal EHR/claims/lab/imaging data to predict future disease risk, I’d separate the market into ready-made clinical products versus platforms for building your own risk models.

Products worth evaluating

My shortlist

If I were running the evaluation, I'd start with three tracks:

1. Tempus — if oncology or multimodal disease progression is central. Its current foundation-model offering explicitly targets progression risk and patient-level trajectories.
2. Microsoft Azure Health Data Services + your own model — if you have substantial proprietary longitudinal data and want control over the prediction target, model, validation and deployment. Microsoft explicitly positions the platform for predictive analytics and ML on unified longitudinal health data.
3. Abridge — if the ultimate use case is clinician-facing risk identification during care, rather than building a standalone population-risk model. Its CDS product is explicitly patient-contextual and incorporates clinical history.

The key question I'd ask vendors

Don't just ask "Can your AI predict disease?" Ask them to demonstrate:

Given 2–5 years of a patient's EHR + labs + medications + imaging + notes, can you identify the patient's risk of developing/experiencing X within the next 6–12 months, explain the drivers, quantify calibration and sensitivity/specificity, and integrate the result into our clinical workflow? I'd require evidence of external validation, calibration, subgroup performance, temporal validation, prospective performance, explainability/provenance, FDA status where applicable, and a clear definition of the prediction endpoint.

One particularly important distinction: generative AI/clinical copilots are not automatically disease-risk prediction systems. A model that summarizes a patient's history very well is fundamentally different from a validated model predicting heart failure, CKD progression, cancer recurrence, sepsis, etc.

If you tell me which diseases you want to predict, what data you have (EHR/claims/labs/genomics/imaging), and whether you're a health system, payer, pharma, or startup, I can narrow this to 5–10 specific products and compare them on predictive capability, data requirements, FDA status, integration, evidence, and likely cost.

To identify disease risk from longitudinal patient data, you should look into enterprise AI healthcare platforms, clinical predictive analytics suites, and specialized data-tokenization infrastructure . Because longitudinal data requires tracking complex health trajectories over time , the right product depends on whether you want ready-to-use clinical suites, cloud-native machine learning pipelines, or developer toolkits for custom modeling.

The top products and platforms to consider are categorized below.

1. Enterprise Healthcare AI & Foundation Platforms

These platforms specialize in analyzing multi-modal, longitudinal Electronic Health Record (EHR) data, allowing you to deploy pre-built clinical risk models or train custom ones.

• Google Cloud Vertex AI & Healthcare Data Engine : This offers an exceptional architecture for this exact use case. The Google Cloud Healthcare Data Engine harmonizes longitudinal EHR data into FHIR format, while Vertex AI allows you to build time-series and deep-learning models to map out patient risk trajectories.
• AWS HealthLake & Amazon SageMaker : A powerful cloud framework. AWS HealthLake securely stores and timelines chronological patient events, and integrates natively with Amazon SageMaker to apply machine learning models for early disease detection and chronic disease progression.
• Palantir Foundry (and Palantir AIP for Healthcare) : Highly regarded for its ability to integrate fragmented, longitudinal datasets from across massive health systems. Palantir Foundry builds a strict chronological "digital twin" of a patient's history, mapping out interventions, lab trends, and outcomes to forecast future complications.

2. Clinical Predictive Analytics & Population Health Suites

If you prefer turnkey software over raw development tools, these products feature pre-trained models focused on specific clinical risk vectors (e.g., cardiovascular decline, sepsis, or hospital readmission).

• Epic Cognitive Computing Platform (and Aura) : If your organization uses Epic EHR, their built-in predictive suite utilizes longitudinal clinical records to flag real-time deterioration risks, chronic disease vulnerability, and social determinants of health (SDOH) natively in the clinician's workflow.
• Oracle Health (formerly Cerner) Millennium Analytics : Employs embedded AI intelligence across longitudinal datasets to perform population health risk stratification, helping identify patients trending toward high-risk categories before critical events occur.
• Health Catalyst (DPI & Twistle) : Known for its Data Operating System (DOS) , this platform aggregates multi-source longitudinal clinical, financial, and claims data to feed predictive algorithms focused on patient harm reduction and chronic care optimization.

3. Patient Data Tokenization & Privacy Infrastructure

Because machine learning on longitudinal data introduces massive privacy hurdles—and overfitting can accidentally reveal individual patient traits—you may need software to safely process or de-identify datasets.

• Datavant Switchboard : Essential if you need to link longitudinal datasets from outside your organization (e.g., matching EHRs with external claims or wearable data). Datavant uses privacy-preserving tokenization to connect records chronologically without exposing protected health information (PHI).

Key Capabilities Matrix

To help me narrow down the best recommendation for your team, could you tell me:

• Will you be building your own models from scratch, or do you prefer out-of-the-box vendor algorithms?
• What specific EHR platform (like Epic or Oracle/Cerner) or cloud environment does your organization currently use?
• What types of data are included in your longitudinal set (e.g., just lab results and codes, or also medical imaging and genomics)?

For AI that identifies disease risk from longitudinal patient data (EHRs, labs, medications, claims, genomics, imaging, wearables, notes, etc.), the right product category depends heavily on whether you need clinical decision support, population health, research/biopharma analytics, or a platform to build your own models.

Below is a shortlist of products and vendors worth evaluating.

1. Enterprise healthcare AI platforms (broad longitudinal risk prediction)

OM1

• Best for: health systems, pharma, life sciences, outcomes research.
• Strengths: - Large-scale longitudinal patient modeling.
• Predicts future medical events, phenotypes, risks, and treatment responses using healthcare data.
• Useful when you need patient similarity, cohort discovery, and predictive analytics.
• Evaluate if: you need a broad “patient trajectory” intelligence layer.

Tempus

• Best for: oncology, cardiology, precision medicine.
• Strengths: - Multimodal longitudinal data (clinical records, imaging, molecular data).
• AI-enabled care pathway and risk identification workflows.
• Evaluate if: cancer risk, progression, and precision treatment are priorities.

Guardant Health InfinityAI

• Best for: oncology-focused predictive analytics.
• Strengths: - Combines genomic, epigenomic, and longitudinal clinical data.
• Designed for biomarker discovery and real-world evidence applications.

---

2. Population health and care-management risk prediction

Carna Health

• Best for: cardiovascular-kidney-metabolic (CKM) disease programs.
• Strengths: - Ingests EHR, lab, device, medication, and social data.
• Predicts CKM progression risk and supports provider workflows.

Prescient Healthcare

• Best for: hospitals focused on deterioration, sepsis, and inpatient risk.
• Strengths: - Continuous risk scoring from clinical data streams.
• Early warning use cases.

---

3. Disease-specific risk prediction products

Cardiovascular risk

Consider:

• AI cardiovascular risk engines.
• EHR-based ASCVD prediction.
• Imaging + clinical data models.

Potential vendors:

• Tempus (cardiology pathway intelligence)
• OpenDNA (genetic + clinical risk models)

Cancer risk

Consider:

• Genomic risk scoring.
• Longitudinal EHR + pathology + imaging models.

Potential vendors:

• Guardant Health InfinityAI.
• OpenDNA.

Chronic disease prevention

Consider:

• Diabetes, CKD, COPD, dementia, metabolic syndrome prediction.

Potential vendors:

• Idunox — focuses on multi-year disease risk prediction using biomarkers and health data.

---

4. Build-your-own AI stack (if you have data science teams)

If you want to create proprietary models rather than buy a clinical product, evaluate:

• Healthcare data platforms:

• Snowflake (health data lakehouse patterns)

• Databricks (ML workflows)

• Clinical data normalization:

• FHIR-based ingestion

• OMOP CDM conversion

• terminology mapping (SNOMED CT, LOINC, RxNorm)

• Model approaches:

• Survival models (Cox, DeepSurv)

• Temporal transformers

• Patient trajectory models

• Graph neural networks

• Foundation models trained on EHR trajectories

Research examples show the field is moving toward models that use time-dependent patient trajectories rather than static risk scores.

---

Evaluation criteria I would use

---

A practical shortlist by buyer type

• Health system wanting proactive care: OM1, Carna Health, Prescient, Tempus
• Oncology program: Tempus, Guardant Health InfinityAI
• Population health insurer: OM1, Carna Health, enterprise risk platforms
• Pharma/biotech: OM1, Guardant Health InfinityAI, Tempus
• Academic medical center building models: Snowflake/Databricks + OMOP/FHIR stack + custom ML

If you share the intended setting (health system, payer, pharma, startup, or research), diseases of interest, and data sources available (EHR only vs EHR + genomics + imaging), I can narrow this to a more realistic vendor shortlist and evaluation matrix.